Form 8-K - Current report:
SEC Accession No. 0001193125-26-179214
Filing Date
2026-04-27
Accepted
2026-04-27 08:31:16
Documents
9
Period of Report
2026-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K eras-20260427.htm   iXBRL 8-K 48020
  Complete submission text file 0001193125-26-179214.txt   158428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20260427.xsd EX-101.SCH 25793
12 EXTRACTED XBRL INSTANCE DOCUMENT eras-20260427_htm.xml XML 4879
Mailing Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 26896697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)